Primary |
Drug Use For Unknown Indication |
59.3% |
Benign Prostatic Hyperplasia |
8.8% |
Hypertension |
6.3% |
Prostatitis |
2.9% |
Pain |
2.4% |
Product Used For Unknown Indication |
2.2% |
Depression |
1.7% |
Epilepsy |
1.7% |
Urinary Tract Infection |
1.7% |
Anxiety |
1.5% |
Dyslipidaemia |
1.5% |
Renal Transplant |
1.5% |
Urinary Retention |
1.5% |
Hypothyroidism |
1.2% |
Prostatic Adenoma |
1.2% |
Angina Pectoris |
1.0% |
Benign Prostatic Hypertrophy |
1.0% |
Insomnia |
1.0% |
Pulmonary Embolism |
1.0% |
Bronchitis |
0.7% |
|
Thrombocytopenia |
11.6% |
Rhabdomyolysis |
8.7% |
Atrial Fibrillation |
7.2% |
Urinary Retention |
7.2% |
Psoriasis |
5.8% |
Renal Failure Acute |
5.8% |
Toxic Skin Eruption |
5.8% |
Death |
4.3% |
Myocardial Infarction |
4.3% |
Osteonecrosis |
4.3% |
Pancreatitis |
4.3% |
Pyrexia |
4.3% |
Rash Maculo-papular |
4.3% |
Somnolence |
4.3% |
Agranulocytosis |
2.9% |
Eosinophilia |
2.9% |
Interstitial Lung Disease |
2.9% |
Iris Disorder |
2.9% |
Lichenoid Keratosis |
2.9% |
Macular Degeneration |
2.9% |
|
Secondary |
Drug Use For Unknown Indication |
34.8% |
Product Used For Unknown Indication |
12.0% |
Hypertension |
10.6% |
Benign Prostatic Hyperplasia |
6.2% |
Angina Pectoris |
4.5% |
Cardiac Failure |
3.8% |
Pain |
3.6% |
Diabetes Mellitus |
2.7% |
Bronchitis |
2.6% |
Gastrooesophageal Reflux Disease |
2.6% |
Infection |
2.4% |
Insomnia |
2.4% |
Type 2 Diabetes Mellitus |
2.1% |
Anxiety |
1.5% |
Atrial Fibrillation |
1.5% |
Prostate Cancer |
1.5% |
Urinary Retention |
1.5% |
Essential Hypertension |
1.4% |
Epilepsy |
1.2% |
Hypokalaemia |
1.2% |
|
Orthostatic Hypotension |
9.9% |
Renal Failure |
9.9% |
Thrombocytopenia |
8.9% |
Rhabdomyolysis |
7.9% |
Haematoma |
6.9% |
Malaise |
6.9% |
Pancreatitis |
6.9% |
Renal Failure Acute |
5.0% |
Somnolence |
5.0% |
Toxic Skin Eruption |
4.0% |
Vomiting |
4.0% |
White Blood Cell Count Increased |
4.0% |
Metabolic Alkalosis |
3.0% |
Prostate Cancer |
3.0% |
Pulmonary Alveolar Haemorrhage |
3.0% |
Tendon Rupture |
3.0% |
Thrombosis |
3.0% |
Agranulocytosis |
2.0% |
Cholestasis |
2.0% |
Coma |
2.0% |
|
Concomitant |
Drug Use For Unknown Indication |
29.6% |
Product Used For Unknown Indication |
17.0% |
Hypertension |
9.8% |
Benign Prostatic Hyperplasia |
6.0% |
Pain |
4.0% |
Depression |
3.8% |
Prophylaxis |
3.2% |
Atrial Fibrillation |
2.9% |
Hiv Infection |
2.4% |
Ill-defined Disorder |
2.4% |
Thrombosis Prophylaxis |
2.2% |
Anxiety |
2.2% |
Diabetes Mellitus |
2.2% |
Renal Transplant |
2.0% |
Hypercholesterolaemia |
1.8% |
Prostatic Adenoma |
1.8% |
Parkinson's Disease |
1.8% |
Dyslipidaemia |
1.6% |
Insomnia |
1.6% |
Multiple Sclerosis |
1.6% |
|
Vomiting |
10.2% |
Renal Failure Acute |
9.8% |
Thrombocytopenia |
9.8% |
Renal Failure |
8.3% |
Weight Decreased |
6.3% |
Somnolence |
5.4% |
Urinary Retention |
5.4% |
Urinary Tract Infection |
5.4% |
Myocardial Infarction |
4.4% |
Progressive Multifocal Leukoencephalopathy |
3.9% |
Pyrexia |
3.9% |
Rash |
3.4% |
Syncope |
3.4% |
Toxic Skin Eruption |
3.4% |
Jaundice |
2.9% |
Neutropenia |
2.9% |
Septic Shock |
2.9% |
Tremor |
2.9% |
Weight Increased |
2.9% |
Cytolytic Hepatitis |
2.4% |
|
Interacting |
Abdominal Hernia |
28.6% |
Anxiety |
14.3% |
Benign Prostatic Hyperplasia |
14.3% |
Chronic Obstructive Pulmonary Disease |
14.3% |
Depression |
14.3% |
Hypertension |
14.3% |
|
Orthostatic Hypotension |
50.0% |
Syncope |
50.0% |
|